Leukotriene E4 ≥98%
Supplier: Enzo Life Sciences
|
Danger
|
BML-LE004-0050
BML-LE004-1000
89160-514EA
469.26
CAD
89160-514
89160-516
Leukotriene E4 ≥98%
Leukotriene E4
Prostanoid receptor ligand.
- Formulation: Liquid.
Less potent than LTD4 in smooth muscle contractile activity and mucus secretion in airways. Reduces myocardial contractility and coronary blood flow. Induces long lasting hypotension and airway hyperresponsiveness. Partial agonist at LTD4 receptors. LTE4 solely activates a CysLT1 receptor. Biosynthesis from LTD4 by a dipeptidase.
Formula:
C₂₃H₃₇NO₅S MW: 439.6 g/mol Storage Temperature: Ultra-Low Temperature Freezer (–80°C) |
CAS Number:
75715-89-8 UN: 1992 ADR: 3 II |
|
Specification Test Results
Concentration | 50 µg/mL |
Formulation | Solution in methanol/ammonium acetate buffer, 70:30, pH 5.6. |
Purity | ≥98% (HPLC) |
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...